van Doorn PA - Search Results

1

Anti-beta-tubulin antibodies have no diagnostic value in patients with chronic inflammatory demyelinating polyneuropathy.

van Schaik IN, Vermeulen M, van Doorn PA, Brand A. van Schaik IN, et al. Among authors: van doorn pa. J Neurol. 1995 Sep;242(9):599-603. doi: 10.1007/BF00868814. J Neurol. 1995. PMID: 8551323

2

Intravenous immunoglobulin treatment in patients with chronic inflammatory demyelinating polyneuropathy. Clinical and laboratory characteristics associated with improvement.

van Doorn PA, Vermeulen M, Brand A, Mulder PG, Busch HF. van Doorn PA, et al. Arch Neurol. 1991 Feb;48(2):217-20. doi: 10.1001/archneur.1991.00530140113024. Arch Neurol. 1991. PMID: 1847041

3

HLA antigens in patients with chronic inflammatory demyelinating polyneuropathy.

van Doorn PA, Schreuder GM, Vermeulen M, d'Amaro J, Brand A. van Doorn PA, et al. J Neuroimmunol. 1991 May;32(2):133-9. doi: 10.1016/0165-5728(91)90005-r. J Neuroimmunol. 1991. PMID: 1849516

4

On the mechanism of high-dose intravenous immunoglobulin treatment of patients with chronic inflammatory demyelinating polyneuropathy.

van Doorn PA, Rossi F, Brand A, van Lint M, Vermeulen M, Kazatchkine MD. van Doorn PA, et al. Among authors: van lint m. J Neuroimmunol. 1990 Sep-Oct;29(1-3):57-64. doi: 10.1016/0165-5728(90)90147-f. J Neuroimmunol. 1990. PMID: 2211989

5

The mechanism of action of intravenous immunoglobulin in patients with chronic inflammatory demyelinating polyneuropathy.

Brand A, Van Doorn PA, Rossi F, Kazatchkine MD, Vermeulen M. Brand A, et al. Among authors: van doorn pa. Prog Clin Biol Res. 1990;337:405-9. Prog Clin Biol Res. 1990. PMID: 2353004 No abstract available.

6

High-dose intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy: a double-blind, placebo-controlled, crossover study.

van Doorn PA, Brand A, Strengers PF, Meulstee J, Vermeulen M. van Doorn PA, et al. Neurology. 1990 Feb;40(2):209-12. doi: 10.1212/wnl.40.2.209. Neurology. 1990. PMID: 2405291 Clinical Trial.

7

Regulation of autoantibodies in inflammatory demyelinating polyneuropathy: spontaneous and therapeutic.

Lundkvist I, van Doorn PA, Vermeulen M, van Lint M, van Rood JJ, Brand A. Lundkvist I, et al. Among authors: van rood jj, van lint m, van doorn pa. Immunol Rev. 1989 Aug;110:105-17. doi: 10.1111/j.1600-065x.1989.tb00029.x. Immunol Rev. 1989. PMID: 2676844 Review.

8

Anti-neuroblastoma cell line antibodies in inflammatory demyelinating polyneuropathy: inhibition in vitro and in vivo by IV immunoglobulin.

van Doorn PA, Brand A, Vermeulen M. van Doorn PA, et al. Neurology. 1988 Oct;38(10):1592-5. doi: 10.1212/wnl.38.10.1592. Neurology. 1988. PMID: 2843794

9

Association of HLA-DR2 antigen with serum IgG antibodies against Borrelia burgdorferi in Bannwarth's syndrome.

Wokke JH, van Doorn PA, Brand A, Schreuder GM, Vermeulen M. Wokke JH, et al. Among authors: van doorn pa. J Neurol. 1988 Sep;235(7):415-7. doi: 10.1007/BF00314484. J Neurol. 1988. PMID: 3265432

10

Clinical significance of antibodies against peripheral nerve tissue in inflammatory polyneuropathy.

van Doorn PA, Brand A, Vermeulen M. van Doorn PA, et al. Neurology. 1987 Nov;37(11):1798-802. doi: 10.1212/wnl.37.11.1798. Neurology. 1987. PMID: 3670618

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

427 results

Search Page

Filters